Unavailable
Unavailable
Save time and jump to the most important pieces.
OSR Holdings, Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday, February 18, 2025Under the symbol "OSRH" SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR Holdings Co., Ltd. ("OSR") announced today the completion of their business combination (the "Business Combination"). The Company now operates as "OSR Holdings, Inc." following the successful completion of the Business Combination. Beginning on Tuesday, February 18, 2025, the common stock and warrants of the Company
SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders (the "Special Meeting") held today, including the proposal for the business combination with OSR Holdings Co., Ltd. (the "Transaction"). BLAC expects the Transaction to close following receipt of foreign investment approval from the Industrial Bank of Korea, which is expected on February 14, 2025. Following the Special Meeting, BLAC filed its Amended and Restated Certific
BELLEVUE, Wash., May 13, 2024 /PRNewswire/ -- As previously announced, on May 10, 2024, Bellevue Life Sciences Acquisitions Corp. (NASDAQ:BLAC) ("BLAC") convened a special meeting of stockholders (the "Special Meeting"), adjourned the Special Meeting without any business being conducted, and announced that the Special Meeting will be reconvened at 9:00 a.m. Pacific time on Tuesday, May 14, 2024, at 925 Fourth Avenue, Suite 2900, Seattle, WA 98104. At the reconvened Special Meeting, stockholders will consider and vote upon the matters described in BLAC's definitive proxy statement filed with the U.S. Securities and Exchange Commission (the "SEC") on April 26, 2024 (the "Proxy Statement"). BL
3 - OSR Holdings, Inc. (0001840425) (Issuer)
3 - OSR Holdings, Inc. (0001840425) (Issuer)
3 - OSR Holdings, Inc. (0001840425) (Issuer)
SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
SC 13G/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
SC 13G - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
8-K - OSR Holdings, Inc. (0001840425) (Filer)
25-NSE - OSR Holdings, Inc. (0001840425) (Subject)
425 - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)